“Selective Safety Data Collection in Clinical Studies of Oncology Drugs for Marketing Approval in the United States”. Journal of Regulatory Science, vol. 5, no. 2, Aug. 2017, pp. 36-44, https://doi.org/10.21423/JRS-V05N02P029.